Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An observational study

INTRODUCTION: Treatment of severe rheumatoid arthritis (RA) is currently based either on biological agents or Janus kinase/signal transducer and activator of transcription inhibitors, most often in combination with methotrexate (MTX). AIM OF THE STUDY: The aim of the study was to compare the effecti...

Descripción completa

Detalles Bibliográficos
Autor principal: Wisłowska, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238315/
https://www.ncbi.nlm.nih.gov/pubmed/35782030
http://dx.doi.org/10.5114/reum.2022.115987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238315/
https://www.ncbi.nlm.nih.gov/pubmed/35782030
http://dx.doi.org/10.5114/reum.2022.115987

Ejemplares similares